Reimagining brain health through new insights into synaptic biology

Syndeio is pioneering a breakthrough class of synaptic therapies to transform the treatment landscape for neuropsychiatric and cognitive disorders. Through unparalleled expertise in fundamental synapse biology and a leading synapse pharmacology platform, Syndeio is developing drug candidates with novel, differentiated mechanisms of action to unlock rapid-acting, safe, and effective therapies.